Isoxazole-thiazole derivatives as GABA A receptor inverse agonists for use in the treatment of cognitive disorders

Details for Australian Patent Application No. 2010244551 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Jakob-Roetne, Roland; Lucas, Matthew C.; Thomas, Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2010244551

PCT Pub. Number WO2010/127974

Priority 09159411.9 05.05.09 EP

Filing date 28 April 2010

Wipo publication date 11 November 2010

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 (2006.01) - Thiazoles

A61K 31/4439 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/127974 Priority application(s): WO2010/127974

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010244552-Isoxazole-pyrazole derivatives

2010244546-Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same